SYN Annual Current Assets
$68.86 M
+$60.92 M+767.89%
31 December 2021
Summary:
As of February 4, 2025, SYN annual total current assets is $68.86 million, with the most recent change of +$60.92 million (+767.89%) on December 31, 2021. During the last 3 years, it has risen by +$39.35 million (+133.33%).SYN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Quarterly Current Assets
$54.89 M
-$4.67 M-7.84%
30 June 2022
Summary:
As of February 4, 2025, SYN quarterly total current assets is $54.89 million, with the most recent change of -$4.67 million (-7.84%) on June 30, 2022. Over the past year, it has dropped by -$20.74 million (-27.43%).SYN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +767.9% | -27.4% |
| 3 y3 years | +133.3% | +138.5% |
| 5 y5 years | +283.8% | +268.0% |
SYN Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -30.2% |
Synthetic Biologics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $54.89 M(-7.8%) |
| Mar 2022 | - | $59.55 M(-13.5%) |
| Dec 2021 | $1.51 M(+216.6%) | $68.86 M(-6.4%) |
| Sept 2021 | - | $73.56 M(-2.7%) |
| June 2021 | - | $75.63 M(-3.8%) |
| Mar 2021 | - | $78.64 M(+891.1%) |
| Dec 2020 | $476.00 K(-41.2%) | $7.93 M(+19.1%) |
| Sept 2020 | - | $6.66 M(-25.6%) |
| June 2020 | - | $8.96 M(-19.8%) |
| Mar 2020 | - | $11.17 M(-32.0%) |
| Dec 2019 | $809.00 K(+28.4%) | $16.43 M(-17.2%) |
| Sept 2019 | - | $19.84 M(-13.8%) |
| June 2019 | - | $23.01 M(-10.0%) |
| Mar 2019 | - | $25.55 M(-13.4%) |
| Dec 2018 | $630.00 K(-29.6%) | $29.51 M(+192.0%) |
| Sept 2018 | - | $10.11 M(+31.9%) |
| June 2018 | - | $7.66 M(-34.2%) |
| Mar 2018 | - | $11.64 M(-35.1%) |
| Dec 2017 | $895.00 K(-3.6%) | $17.94 M(-19.6%) |
| Sept 2017 | - | $22.31 M(+49.6%) |
| June 2017 | - | $14.92 M(-11.4%) |
| Mar 2017 | - | $16.84 M(-21.9%) |
| Dec 2016 | $928.00 K(+82.7%) | $21.57 M(+182.3%) |
| Sept 2016 | - | $7.64 M(-51.7%) |
| June 2016 | - | $15.82 M(-28.8%) |
| Mar 2016 | - | $22.22 M(-26.8%) |
| Dec 2015 | $508.00 K(+615.5%) | $30.34 M(-28.0%) |
| Sept 2015 | - | $42.14 M(+259.8%) |
| June 2015 | - | $11.71 M(-14.0%) |
| Mar 2015 | - | $13.62 M(-28.6%) |
| Dec 2014 | $71.00 K(+73.2%) | $19.07 M(+308.6%) |
| Sept 2014 | - | $4.67 M(-49.4%) |
| June 2014 | - | $9.23 M(-26.1%) |
| Mar 2014 | - | $12.49 M(-23.0%) |
| Dec 2013 | $41.00 K(-95.7%) | $16.22 M(+138.8%) |
| Sept 2013 | - | $6.79 M(-28.2%) |
| June 2013 | - | $9.46 M(-17.4%) |
| Mar 2013 | - | $11.45 M(-8.1%) |
| Dec 2012 | $960.00 K(+171.2%) | $12.46 M(+157.0%) |
| Sept 2012 | - | $4.85 M(-22.7%) |
| June 2012 | - | $6.27 M(-14.4%) |
| Mar 2012 | - | $7.33 M(+2.9%) |
| Dec 2011 | $354.00 K(-37.5%) | $7.12 M(-12.0%) |
| Sept 2011 | - | $8.09 M(-9.1%) |
| June 2011 | - | $8.91 M(+35.3%) |
| Mar 2011 | - | $6.58 M(+85.7%) |
| Dec 2010 | $566.00 K(-57.2%) | $3.54 M(-4.2%) |
| Sept 2010 | - | $3.70 M(+7.5%) |
| June 2010 | - | $3.44 M(+66.1%) |
| Mar 2010 | - | $2.07 M(-24.7%) |
| Dec 2009 | $1.32 M | $2.75 M(-24.7%) |
| Sept 2009 | - | $3.66 M(-19.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $4.51 M(-15.7%) |
| Mar 2009 | - | $5.36 M(-9.6%) |
| Dec 2008 | $1.46 M(-29.8%) | $5.93 M(-8.7%) |
| Sept 2008 | - | $6.49 M(-13.6%) |
| June 2008 | - | $7.52 M(-15.0%) |
| Mar 2008 | - | $8.85 M(-23.5%) |
| Dec 2007 | $2.08 M(+598.5%) | $11.56 M(+56.8%) |
| Sept 2007 | - | $7.37 M(-19.3%) |
| June 2007 | - | $9.13 M(-16.8%) |
| Mar 2007 | - | $10.97 M(-10.2%) |
| Dec 2006 | $297.30 K(+5.4%) | $12.22 M(>+9900.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(-100.0%) |
| Dec 2005 | $282.10 K(-58.5%) | - |
| Mar 2003 | - | $574.10 K(-31.3%) |
| Dec 2002 | $679.30 K(-0.6%) | $835.30 K(-21.5%) |
| Sept 2002 | - | $1.06 M(-32.0%) |
| June 2002 | - | $1.56 M(-5.1%) |
| Mar 2002 | - | $1.65 M(+20.0%) |
| Dec 2001 | $683.40 K(+26.3%) | $1.37 M(-48.0%) |
| Sept 2001 | - | $2.64 M(-7.6%) |
| June 2001 | - | $2.86 M(-7.3%) |
| Mar 2001 | - | $3.08 M(-37.2%) |
| Dec 2000 | $541.00 K(+6.2%) | $4.91 M(+67.3%) |
| Sept 2000 | - | $2.93 M(-15.3%) |
| June 2000 | - | $3.46 M(-40.7%) |
| Mar 2000 | - | $5.84 M(+28.7%) |
| Dec 1999 | $509.60 K(+94.1%) | $4.54 M(+249.2%) |
| Sept 1999 | - | $1.30 M(-18.8%) |
| June 1999 | - | $1.60 M(-23.8%) |
| Mar 1999 | - | $2.10 M(-19.2%) |
| Dec 1998 | $262.50 K(+31.3%) | $2.60 M(-10.3%) |
| Sept 1998 | - | $2.90 M(-50.8%) |
| June 1998 | - | $5.90 M(+5800.0%) |
| Mar 1998 | - | $100.00 K(-80.0%) |
| Dec 1997 | $200.00 K(-33.3%) | $500.00 K(-54.5%) |
| Sept 1997 | - | $1.10 M(+37.5%) |
| June 1997 | - | $800.00 K(-75.8%) |
| Mar 1997 | - | $3.30 M(+32.0%) |
| Dec 1996 | $300.00 K(+50.0%) | $2.50 M(-41.9%) |
| Sept 1996 | - | $4.30 M(-17.3%) |
| June 1996 | - | $5.20 M(+147.6%) |
| Mar 1996 | - | $2.10 M(+5.0%) |
| Dec 1995 | $200.00 K(-33.3%) | $2.00 M(-37.5%) |
| Sept 1995 | - | $3.20 M(+3100.0%) |
| Dec 1994 | $300.00 K(+200.0%) | $100.00 K(-97.8%) |
| Mar 1994 | - | $4.60 M(+170.6%) |
| Dec 1993 | $100.00 K | $1.70 M(-41.4%) |
| Sept 1993 | - | $2.90 M(-34.1%) |
| June 1993 | - | $4.40 M(-12.0%) |
| Mar 1993 | - | $5.00 M |
FAQ
- What is Synthetic Biologics annual total current assets?
- What is the all time high annual current assets for Synthetic Biologics?
- What is Synthetic Biologics annual current assets year-on-year change?
- What is Synthetic Biologics quarterly total current assets?
- What is the all time high quarterly current assets for Synthetic Biologics?
- What is Synthetic Biologics quarterly current assets year-on-year change?
What is Synthetic Biologics annual total current assets?
The current annual current assets of SYN is $68.86 M
What is the all time high annual current assets for Synthetic Biologics?
Synthetic Biologics all-time high annual total current assets is $68.86 M
What is Synthetic Biologics annual current assets year-on-year change?
Over the past year, SYN annual total current assets has changed by +$60.92 M (+767.89%)
What is Synthetic Biologics quarterly total current assets?
The current quarterly current assets of SYN is $54.89 M
What is the all time high quarterly current assets for Synthetic Biologics?
Synthetic Biologics all-time high quarterly total current assets is $78.64 M
What is Synthetic Biologics quarterly current assets year-on-year change?
Over the past year, SYN quarterly total current assets has changed by -$20.74 M (-27.43%)